Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Drug-induced myopathies.

Current opinion in neurology - 1 Oct 2008

Klopstock Thomas

Abstract excerpt

PURPOSE OF REVIEW: Drug-induced muscle disorders are important causes of morbidity, but the risk-benefit profile of the incriminated drugs must be put into perspective. This review highlights some recent advances on statin-induced and antiretroviral drug-induced myopathies and calls attention to some less familiar myotoxic disorders. RECENT FINDINGS: In statin myopathy, reduction of coenzyme Q has been discussed...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antiretroviral Therapy, Highly Active
Share to Dermatomyositis
Share to Fluoroquinolones

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genetic Predisposition to Disease

Share to Hydroxymethylglutaryl-CoA Reductase Inhibitors

Share to Muscle, Skeletal

Share to Muscular Diseases

Source

Identifiers

PMID: 18769254
DOI: 10.1097/WCO.0b013e32830e2774

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Drug-induced myopathies.PMID 18769254Read ↗

Iatrogenic myopathies.Semantic proximity Read ↗

Clinical characterization and molecular mechanisms of statin myopathy.Semantic proximity Read ↗

Agents and mechanisms of toxic myopathy.Semantic proximity Read ↗

Statin-associated myopathy: from genetic predisposition to clinical management.Semantic proximity Read ↗

Approach to clinical and genetic characterization of statin-induced myopathy.Semantic proximity Read ↗

Statin-induced myopathy.Semantic proximity Read ↗

Statin induced myotoxicity.Semantic proximity Read ↗

Statin-Related Myotoxicity: A Comprehensive Review of Pharmacokinetic, Pharmacogenomic and Muscle ComponentsSemantic proximity Read ↗

Statin myotoxicity: a review of genetic susceptibility factors.Semantic proximity Read ↗

The genetics of statin-induced myopathy.Semantic proximity Read ↗

Pharmacogenomic insights into treatment and management of statin-induced myopathySemantic proximity Read ↗

Genetic predisposition to statin myopathy.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.